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Sodium hyaluronate inhibits interleukin-1-evoked reactive oxygen
species of bovine articular chondrocytes
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Department of Orthopedic Surgery, Kinki University School of Medicine, Ohno-higashi 377-2, Osaka-sayama,
Osaka 589-8511, JapanIntroduction
Interleukin-1 (IL-1) is one of the key cytokines involved in
the process of osteoarthritis (OA). In IL-1-mediated carti-
lage degradation, we demonstrated the involvement of
reactive oxygen species (ROS), such as superoxide
anion1, nitric oxide (NO)2, peroxynitrite3 and hydrogen
peroxide4. For the treatment of OA of the knee, intraarticu-
lar sodium hyaluronate (HA) derivatives are often used.
However, there is limited data about the action of HA on
ROS. In the present study, we demonstrated the inhibitory
effect of HA on IL-1-evoked ROS synthesis in situ using
2,7-dihydrodichlorofluorescein diacetate (DCF-DA), which
is a fluorogenic compound and a marker for oxidative
stress5.Material and method
Human recombinant IL-1- was purchased from R&D
systems (Minneapolis, MN). 2,7-dichlorofluorescin di-
acetate (DCF-DA) was purchased from Molecular Probes
(Eugene, OR). Purified sodium hyaluronate, with molecular
weight of approximately 90 kD, and fluoresceinamine-
labeled sodium hyaluronate were gifts from Seikagaku
Corp. (Tokyo, Japan).CHONDROCYTE CULTURE
Bovine radiocarpal joint was obtained from a local
slaughterhouse, as described elsewhere6.390ALGINATE BEADS CULTURE
Bovine articular chondrocytes were suspended in 1.2%
alginate in 0.9% NaCl at a density of 4×106 cells/ml, then
passed drop wise through a 22-gauge needle into 100 mM
CaCl2 solution. After 10 min of polymerization, the beads
were washed three times in 0.9% NaCl and once in DMEM
medium with 10% FBS7.CONFOCAL MICROSCOPE
Samples were incubated with 50 M DCF-DA in Locke’s
solution (154 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl2, 1 mM
MgCl2, 3.6 mM NaHCO3, 15 mM HEPES, 10 mM glucose,
pH 7.3) for 15 min, then washed with the same solution.
Investigation was conducted using a laser scanning confo-
cal microscope (MRC 2400 LSX imaging system; Bio-Rad,
Hertfordshire, U.K.) equipped with an argon laser adjusted
to an output of 250 mW at 488 nm excitation, 525 nm
emission.FLUORESCENT MEASUREMENT
Medium was replaced with Locke’s solution containing
DCF-DA, as described above. Fluorimetric measurement
of DCF oxidation in the cell layers was carried out, by
confocal microscopy. The obtained data were quantitatively
analysed using LaserSharp Processing software and
numerical presentation was conducted as a pixel count.
Six replicates per treatment group were run for each
experiment.STATISTICAL ANALYSIS
Results are presented as the mean±S.D. Significant
differences were determined by Student’s t-test. A sig-
nificance level of P<0.05 was used to reject the null
hypothesis.Received 3 August 1999; revision requested 16 December
1999; revision received 30 August 2000; accepted 30 October
2000; published online 23 March 2001.
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Bovine articular chondrocytes were incubated with IL-1
for 6 h. Confocal microscopy revealed negligible or scanty
Osteoarthritis and Cartilage Vol. 9, No. 4 391Fig. 1. DCF-oxidation with IL-1 treatment. Chondrocytes were
treated with IL-1 for 6 h then the medium was changed to serum-
free medium containing a fluorescent probe, DCF-DA (5 M ).
(A): Control, (B): IL-1 (10 ng/ml), (C): IL-1 (10 ng/ml)+SOD
(100 g/ml). ×200.Fig. 2. Penetration of sodium hyaluronate into the alginate beads.
Chondrocytes embedded in the alginate beads were cultured for
7 days, then the medium was replaced with fresh medium contain-
ing fluorescein-labeled sodium hyaluronate (100 M). After 30 min,
the alginate beads were observed by confocal microscopy (A)
and excited using an argon laser (B). We repeated the same
experiment three times and obtained similar results.Fig. 3. Effect of sodium hyaluronate on IL-1-enhanced DCF-
oxidation. Chondrocytes embedded in the alginate beads were
incubated with IL-1 (10 ng/ml) for 24 h and fluorimetric measure-
ment of DCF-oxidation was carried out by confocal microscopy.
Sodium hyaluronate (100 M) was added 30 min prior to IL-1
challenge. Representative results of three different experiments
are shown. The means of six wells are plotted. Bars represent
standard deviation. *: P<0.01.References
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